Search
Now showing items 1-10 of 27
Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda
(BMC Psychiatry, 2010)
Background: Among patients with HIV infection, depression is the most frequently observed psychiatric disorder. The presence of depressive symptoms and cognitive dysfunction among HIV patients has not been well studied in ...
High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort
(BMC Immunology, 2014)
Background: Up to 40% of HIV-infected individuals receiving Highly Active Antiretroviral Therapy (HAART) have poor CD4+ T-cell recovery. The role of natural killer (NK) cells in immune recovery during HAART is not well ...
Prevalence and associated factors of osteoporosis in HIV infected adults attending MU-JHU outpatient clinic at Mulago National Referral Hospital.
(Namusoke, J. (2014). Prevalence and associated factors of osteoporosis in HIV infected adults attending MU-JHU outpatient clinic at Mulago National Referral Hospital. Unpublished masters thesis. Makerere University, Kampala, Uganda., 2014)
Introduction
Western studies have described and noted an increased prevalence rate of osteoporosis in HIV infected patients. The causes of osteoporosis in this population appear to be multifactorial and likely represent ...
Rolling out antiretrovirals in Africa: there are still challenges ahead
(Infectious Diseases Society of America, 2005-08)
In their article “Lessons Learned from Highly Active Antiretroviral Therapy in Africa,” Akileswaran et al. [1] review the effectiveness of HAART programs in Africa. They report positive health outcomes, including high ...
Factors influencing the acceptance of directly observed therapy in the delivery of anti-retroviral drugs for treatment of Human Immunodeficiency Virus in Urban Uganda
(2008-05)
Background: Directly observed therapy for highly active antiretroviral therapy (DOT-HAART) has the potential to improve adherence and social support in HIV+ patients. Aims were to determine; the level of DOT-HAART acceptance, ...
Zinc status in HIV infected Ugandan children aged 1-5 years: a cross sectional baseline survey
(BioMed Central, 2010)
Background: Low concentrations of serum zinc have been reported in HIV infected adults and are associated with disease progression and an increased risk of death. Few studies have been conducted in HIV infected children ...
HIV immune reconstitution syndrome in sub-Saharan Africa
(Lippincott Williams & Wilkins, 2008)
Over the last 5 years, there has been remarkable progress
in providing HAART to patients in developing countries.
In sub-Saharan Africa alone, the number receiving antiretroviral
therapy (ART) has more than doubled in ...
Factors affecting adherence to cotrimoxazole prophylaxis among HIV/AIDS patients in Rukungiri District, Uganda.
(2009)
INTRODUCTION:
Globally, 33 million people are estimated to be living with HIV of which 22 million are in sub Saharan Africa. In Rukungiri district, 20115 people were estimated to be living with HIV/AIDS. With adherence ...
Evaluation of patients' response to treatment with highly active antiretroviral therapy at the Infectious Diseases Institute, Kampala.
(2009-10)
BACKGROUND:
In Africa, a consideration number of clients get diagnosed with HIV for the first time after a WHO stage 4 illness. Evidence in the developed world shows that individuals who initiate ART with advanced HIV/AIDS ...
Antiretroviral therapy improves cognitive impairment in HIV individuals in Sub-Saharan Africa
(American Academy of Neurology (AAN), 2006)
Abstract—Background: Highly active antiretroviral therapy (HAART) can improve cognitive performance in some patients
with HIV-associated cognitive impairment in the United States. The effect of HAART on HIV dementia ...